Sorafenib and malignant neoplasm progression 
Sorafenib and malignant neoplasm progression Patient Reports February 10, 2012
Sorafenib Side Effects Report #4888252-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with thyroid gland cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: localised infection, malignant neoplasm progression, syncope. Sorafenib dosage: 400 MG, BID; ORAL. Patient recovered.
Sorafenib Side Effects Report #4888250-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with squamous cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Sorafenib dosage: 400 MG, BID; ORAL. Patient died on 07/12/2005.
Sorafenib Side Effects Report #4889352-6
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with squamous cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, dysphagia, malignant neoplasm progression, squamous cell carcinoma. Sorafenib dosage: 400 MG BID ORAL. Patient died on 04/26/2005.
Sorafenib Side Effects Report #4889354-X
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with squamous cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dizziness
, fatigue, malignant neoplasm progression, squamous cell carcinoma. Sorafenib dosage: 400 MG BID ORAL. Patient died on 07/12/2005.Sorafenib Side Effects Report #5595398-5
Sorafenib side effect was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 56 years of age, weighting 216.1 lb, was diagnosed with renal cell carcinoma, diabetes mellitus, hypertension, gout
, hypothyroidism, thrombosis prophylaxis, dyspnoea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, gastritis, grand mal convulsion, haemoglobin decreased, malignant neoplasm progression, pleural effusion, reflux oesophagitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with NOVONORM, BISOPROLOL FUMARATE, ALLOPURINOL, EFEROX, FRAXIPARIN, ALBUTEROL, ATROVENT. Patient was hospitalized. Patient died on 02/18/2006.Sorafenib Side Effects Report #5873207-4
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2008. Female patient, weighting 134.8 lb, was diagnosed with renal cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to liver, metastases to lung, somnolence. Sorafenib dosage: 400 MG PO DAILY. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5856938-1
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2008. Male patient, weighting 152.3 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fall , malignant neoplasm progression, muscular weakness, no therapeutic response, paraesthesia, prostate cancer . Sorafenib dosage: 400 MG BID PO. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, FLUOXETINE, OMEPRAZOLE, MIRALAX, SENNA, INSULIN, IBUPROFEN. Patient was hospitalized. Patient died on 08/19/2008.Sorafenib Side Effects Report #5857420-8
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Aug 25, 2008. Male patient, weighting 152.3 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fall , malignant neoplasm progression, metastasis, muscular weakness, no therapeutic response, paraesthesia, prostate cancer . Sorafenib dosage: 400MG BID PO. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, FLUOXETINE, OMEPRAZOLE, MIRALAX, SENNA, INSULIN, IBUPROFEN. Patient was hospitalized. Patient died on 08/20/2008.Sorafenib Side Effects Report #4898058-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 75 years of age, weighting 221.3 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypoxia, malignant neoplasm progression, pulmonary embolism
, thrombosis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ASPIRIN, LOFIBRA, MORPHINE SULPHATE, ACCUPRIL, DEXAMETHASONE, FOLIC ACID, ZOCOR. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5091518-X
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Dec 23, 2005. Female patient, 74 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, dermal cyst, dyspnoea exertional, heart rate increased, heart valve insufficiency, lung neoplasm malignant, malignant neoplasm progression, pulmonary hypertension . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COMBIVENT, ASPIRIN, NITROGLYCERIN, CARBOPLATIN, TAXOL, SHARK CARTILAGE. Patient was hospitalized. Patient died.Sorafenib Side Effects Report #5266967-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 13, 2007. Male patient, 75 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fatigue, malignant neoplasm progression, non-small cell lung cancer stage iiib, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COLACE, DILAUDID, FENTANYL, LANTUS, PANCREASE, LACTULOSE, LISINOPRIL, SENOKOT. Patient was hospitalized. Patient died on 03/09/2007.
Sorafenib Side Effects Report #5897554-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 23, 2008. Male patient, 72 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood glucose increased, bronchostenosis, haemoptysis, malignant neoplasm progression, palmar-plantar erythrodysaesthesia syndrome, peripheral motor neuropathy. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ALBUTEROL SULPHATE, AVODART, ASPIRIN, ISOSORBIDE, OXYGEN, PREDNISONE. Patient recovered.
Sorafenib Side Effects Report #5306963-4
Sorafenib side effect was reported by a Physician from BRAZIL on Apr 19, 2007. Male patient, 68 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer, diabetes mellitus, lung infection and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, lung infection, lung infiltration, lung squamous cell carcinoma stage iv, malignant neoplasm progression, pneumonitis. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, NPH ILETIN II, KEFLIN. Patient was hospitalized. Patient died on 03/10/2007.
Sorafenib Side Effects Report #5257058-X
Sorafenib side effect was reported by a Physician from GERMANY on Mar 02, 2007. Male patient, 66 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haemolysis, lung neoplasm malignant, malignant neoplasm progression, multi-organ failure. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LISINOPRIL, CONCOR, LEVOTHYROXINE, PANTOZOL, ZOFRAN. Patient was hospitalized. Patient died on 09/17/2006.
Sorafenib Side Effects Report #5623329-8
Sorafenib side effect was reported by a Physician from GERMANY on Feb 01, 2008. Female patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, intestinal infarction, malignant neoplasm progression, mesenteric artery thrombosis, renal infarct. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4991397-2
Sorafenib side effect was reported by a Consumer or non-health professional from ISRAEL on Apr 25, 2006. Male patient, 71 years of age, weighting 160.9 lb, was diagnosed with neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, concomitant disease progression, duodenal ulcer, gastric ulcer, hypertension, malignant neoplasm progression, myocardial ischaemia. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LCV, BAY, ATENOLOL, MEGACE, BONDORMIN, XANAGIS. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4978579-0
Sorafenib side effect was reported by a Consumer or non-health professional from ISRAEL on Apr 06, 2006. Male patient, 71 years of age, weighting 160.9 lb, was diagnosed with neoplasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, duodenal ulcer, gastric ulcer, gastrointestinal haemorrhage, malignant neoplasm progression. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LCV, BAY, ATENOLOL, MEGACE, BONDORMIN, XANAGIS. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5003172-3
Sorafenib side effect was reported by a Health Professional from ISRAEL on May 04, 2006. Male patient, 71 years of age, weighting 160.9 lb, was diagnosed with neoplasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, duodenal ulcer, gastric ulcer, gastrointestinal haemorrhage, malignant neoplasm progression, pancreatic carcinoma metastatic. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LCV, BAY, ATENOLOL, MEGACE, BONDORMIN, XANAGIS, PANCREOFLAT. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5059492-X
Sorafenib side effect was reported by a Physician from UNITED STATES on July 12, 2006. Male patient, 88 years of age, weighting 146.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation
, blood creatine phosphokinase increased, blood creatinine increased, fibrin d dimer increased, lung cancer metastatic, malignant neoplasm progression, ventricular extrasystoles. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LIPITOR, HYZAAR, TOPROL, VITAMIN, ISORBIDE. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #5003295-9
Sorafenib side effect was reported by a Physician from UNITED STATES on May 03, 2006. Male patient, 88 years of age, weighting 146.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation
, blood creatine phosphokinase increased, blood creatinine increased, fibrin d dimer increased, lung cancer metastatic, malignant neoplasm progression, ventricular extrasystoles. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LIPITOR, HYZAAR, TOPROL, VITAMIN, ISORBIDE. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #5142132-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 14, 2006. Male patient, 82 years of age, weighting 114.6 lb, was diagnosed with metastatic renal cell carcinoma, anorexia, arthritis
, dyspnoea, cough, anaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastatic renal cell carcinoma, mucosal inflammation. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MARINOL, ALLOPURINOL, OXYGEN, TESSALON, FERROUS SULPHATE. Patient died on 01/16/2006.Sorafenib Side Effects Report #4888258-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Male patient, 78 years of age, weighting 146.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, atrial fibrillation , constipation , creatine phosphokinase decreased, dry skin, haemoglobin decreased, lung neoplasm, malignant neoplasm progression, nausea . Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with MS CONTIN, VICODIN. Patient was hospitalized. Patient died on 01/08/2006.Sorafenib Side Effects Report #5116723-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Oct 18, 2005. Female patient, 77 years of age, weighting 202.8 lb, was diagnosed with metastatic renal cell carcinoma, platelet aggregation abnormal, gastrointestinal disorder, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bone pain, malignant neoplasm progression, metastatic renal cell carcinoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with AGGRENOX, PROTONIX, SOTOLOL, AVAPRO, ALLOPURINOL, HYDROCHLOROTHIAZDE, LASIX, ARANESP. Patient recovered.Sorafenib Side Effects Report #5108824-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 23, 2005. Male patient, 69 years of age, weighting 130.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: diarrhoea, erythema multiforme, malignant neoplasm progression, renal failure, renal failure acute, respiratory disorder, respiratory distress. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient died on 12/18/2005.
Sorafenib Side Effects Report #5144848-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 31, 2006. Female patient, 69 years of age, weighting 174.2 lb, was diagnosed with metastatic renal cell carcinoma, pain
, anxiety , hypertension, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, duodenal neoplasm, fall , malignant neoplasm progression, pain , small intestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with OXYCONTIN, OXYCODONE, TEMAZEPAM, AMLODIPINE, KLONOPIN, DIOVAN, ATARAX, NPH INSULIN. Patient died on 11/22/2005.Sorafenib Side Effects Report #4984228-8
Sorafenib side effect was reported by a Consumer or non-health professional from POLAND on Apr 13, 2006. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal mass, dehydration, malignant neoplasm progression, metabolic disorder
, metastatic renal cell carcinoma, multi-organ failure, respiratory failure, tumour necrosis. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with ISOSORBID MONONITRANS, METOPROLOL SUCCINATE, ACETYLSALICYLIC ACID SRT, KETOPROFEN, TRAMADOL. Patient died on 12/16/2005.Sorafenib Side Effects Report #5019364-3
Sorafenib side effect was reported by a Physician from UNITED STATES on May 19, 2006. Male patient, 67 years of age, weighting 224.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: colonic obstruction, malignant neoplasm progression, pleuritic pain, small intestinal obstruction. Sorafenib dosage: 400 MG, BID, ORAL. Patient was hospitalized. Patient died on 02/12/2006.
Sorafenib Side Effects Report #5094932-1
Sorafenib side effect was reported by a Physician from FRANCE on Jan 17, 2006. Male patient, 66 years of age, weighting 191.8 lb, was diagnosed with metastatic renal cell carcinoma, hypercholesterolaemia, xeroderma, diarrhoea, palmar-plantar erythrodysaesthesia syndrome, constipation
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , asthenia, hepatomegaly, malignant neoplasm progression, metastatic renal cell carcinoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ZOCOR, DEXERYL, IMODIUM, BIAFINE, TIORFAN. Patient was hospitalized. Patient died on 01/28/2006.Sorafenib Side Effects Report #5574750-8
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2007. Male patient, 64 years of age, weighting 194.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, malignant neoplasm progression, metastases to nervous system, neurological symptom, peroneal nerve palsy, spinal cord compression, spinal cord disorder, urinary incontinence . Sorafenib dosage: 600MG BID PO. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5124939-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2006. Male patient, 63 years of age, weighting 147.7 lb, was diagnosed with metastatic renal cell carcinoma, pain
, dyspnoea, hypertension, cough, ex-smoker, sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gastric perforation, lobar pneumonia, malignant neoplasm progression, metastatic renal cell carcinoma, oedema peripheral, peritonitis, pleural effusion, respiratory failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #4961085-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Male patient, 63 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal perforation, lymphadenopathy, malignant neoplasm progression, metastases to liver, metastases to small intestine, oedema, peritonitis, pleural effusion. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN EXPECTORANT W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.
Sorafenib Side Effects Report #5117776-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Female patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, gingival pain, glossodynia, malignant neoplasm progression, pain in extremity, pruritus. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with PAXIL, BLOOD PRESSURE S NOS. Patient recovered.
Sorafenib Side Effects Report #4961103-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood sodium decreased, cancer pain, haemoglobin decreased, headache , malignant neoplasm progression, wound dehiscence, wound secretion. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4955031-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient, weighting 173.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, duodenal neoplasm, fall , gastrointestinal haemorrhage, malignant neoplasm progression, metastatic renal cell carcinoma. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with OXYCONTIN, OXYCODONE, TEMAZEPAM, AMLODIPINE, KLONOPIN, DIOVAN, ATARAX, NPH INSULIN. Patient died on 11/22/2005.Sorafenib Side Effects Report #5167892-2
Sorafenib side effect was reported by a Physician from UNITED STATES on July 14, 2005. Female patient, 79 years of age, weighting 178.6 lb, was diagnosed with metastatic malignant melanoma, nausea
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastatic malignant melanoma, nausea , orthostatic hypotension, subarachnoid haemorrhage, syncope vasovagal. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with DACARBAZINE, ANZEMET, ATIVAN, COMPAZINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4840636-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Nov 17, 2005. Female patient, 79 years of age, weighting 178.8 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fall
, inappropriate antidiuretic hormone secretion, loss of consciousness, malignant neoplasm progression, metastases to central nervous system, orthostatic hypotension, post procedural complication, post procedural nausea, subarachnoid haemorrhage. Sorafenib dosage: 200 MG, BID; ORAL. During the same period patient was treated with DACARBAZINE, ANZEMET, ATIVAN, COMPAZINE, ZOFRAN, ZESTRIL, FOLIC ACID, CENTRUM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4879633-4
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on Jan 04, 2006. Male patient, 66 years of age, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haematemesis, malignant neoplasm progression, metastatic neoplasm. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, TINZAPARIN. Patient was hospitalized. Patient died on 11/18/2005.
Sorafenib Side Effects Report #4886870-1
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on Jan 13, 2006. Male patient, 66 years of age, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haematemesis, hydronephrosis, malignant neoplasm progression, metastatic malignant melanoma. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, TINZAPARIN. Patient was hospitalized. Patient died on 11/18/2005.
Sorafenib Side Effects Report #4705687-1
Sorafenib side effect was reported by a Health Professional from on June 27, 2005. Male patient, 48 years of age, weighting 144.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fatigue, hypotension, malignant melanoma, malignant neoplasm progression. Sorafenib dosage: unknown. During the same period patient was treated with DACARBAZINE, BENDROFLUAZIDE, LISINOPRIL, FELODIPINE. Patient was hospitalized. Patient died on 10/07/2004.
Sorafenib Side Effects Report #4705687-1
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on June 27, 2005. Male patient, 48 years of age, weighting 144.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fatigue, hypotension, malignant melanoma, malignant neoplasm progression. Sorafenib dosage: unknown. During the same period patient was treated with DACARBAZINE, BENDROFLUAZIDE, LISINOPRIL, FELODIPINE. Patient was hospitalized. Patient died on 10/07/2004.
Sorafenib Side Effects Report #5133516-3
Sorafenib side effect was reported by a Physician from FRANCE on Apr 07, 2006. Male patient, 63 years of age, weighting 143.3 lb, was diagnosed with mesothelioma
, fatigue, chest pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, mesothelioma malignant advanced, supraventricular tachyarrhythmia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, NEURONTIN, EFFERALGAN. Patient was hospitalized. Patient died on 06/07/2006.Sorafenib Side Effects Report #4889345-9
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with mesothelioma
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, mesothelioma . Sorafenib dosage: 400 MG BID ORAL. Patient died on 07/01/2005.Sorafenib Side Effects Report #5144845-1
Sorafenib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 12, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with hepatic neoplasm malignant, prophylaxis, cough, hypertension, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cerebral infarction, hepatic failure, hepatic neoplasm malignant, malignant neoplasm progression, pyrexia, refusal of treatment by relative, transient ischaemic attack. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with TRAMADOL, MAGNESIUM OXIDE, REGROW, NORVASC, GLIBEN, TEMGESIC. Patient was hospitalized. Patient died on 10/29/2006.
Sorafenib Side Effects Report #5178963-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 25, 2006. Female patient, 47 years of age, weighting 240.3 lb, was diagnosed with hepatic neoplasm malignant, nausea
, insomnia, pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , diarrhoea, disease progression, dyspnoea, malignant neoplasm progression, nausea , neutrophil count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, ZOFRAN, LORAZEPAM, FENTANYL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5889106-8
Sorafenib side effect was reported by a Physician from GERMANY on Sept 17, 2008. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fatigue, hepatic neoplasm malignant, hypotension, joint dislocation, malignant neoplasm progression, oral candidiasis, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMID, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #6111082-3
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2009. Female patient, 52 years of age, weighting 166.0 lb, was diagnosed with glioma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: glioblastoma multiforme, malignant neoplasm progression. Sorafenib dosage: 200 MG/ BID. During the same period patient was treated with TEMOZOLOMIDE. Patient died on 02/19/2009.
Sorafenib Side Effects Report #5484024-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2007. Male patient, weighting 217.4 lb, was diagnosed with glioblastoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: glioblastoma multiforme, malignant neoplasm progression, pancreatitis acute. Sorafenib dosage: 400 MG DAYS 1-28 PO BID. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, DEXAMETHASONE, COSOPT, LORAZEPAM. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5109030-8
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 30, 2006. Male patient, 40 years of age, weighting 229.3 lb, was diagnosed with bile duct cancer, depression
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: constipation , depression , duodenal perforation, hyperbilirubinaemia, liver abscess, liver carcinoma ruptured, malignant neoplasm progression, peritonitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with GEMCITABINE, ZOLOFT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5147742-0
Sorafenib side effect was reported by a Physician from ITALY on Oct 27, 2006. Male patient, 77 years of age, was diagnosed with gout
, benign prostatic hyperplasia, hypertension, prophylaxis against gastrointestinal ulcer, bradycardia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to central nervous system, syncope. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with ALLOPURINOL, XATRAL, PERINDOPRIL ERBUMINE, LANSOX, DEXAMETHASONE, MANNITOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5059698-X
Sorafenib side effect was reported by a Health Professional from FRANCE on July 05, 2006. Female patient, 66 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, diarrhoea, dyspnoea, malignant neoplasm progression, malnutrition, performance status decreased, tachycardia. Sorafenib dosage: 200 MG QD ORAL. During the same period patient was treated with LEXOMIL, STILNOX, IXPRIM, DIANTALVIC, TOPALGIC, SKENAN, MORPHINE SULPHATE, LAMALINE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5052119-2
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on July 05, 2006. Male patient, 65 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: confusional state, malignant neoplasm progression. Sorafenib dosage: 400 MG BID ORAL. During the same period patient was treated with ACETAMINOPHEN, IMODIUM, TIORFAN, LOPERAMIDE, CLAMOXYL, TOPALGIC, RIVOTRIL. Patient was hospitalized. Patient died on 06/28/2006.
Sorafenib Side Effects Report #5072199-8
Sorafenib side effect was reported by a Physician from FRANCE on June 23, 2006. Male patient, 65 years of age, was diagnosed with pain
, diarrhoea, bronchitis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure, confusional state, dehydration, malignant neoplasm progression, meningitis , metastases to central nervous system, pulmonary oedema. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ACETAMINOPHEN, IMODIUM, TIORFAN, LOPERAMIDE, CLAMOXYL, TOPALGIC, RIVOTRIL. Patient was hospitalized. Patient died on 06/28/2006.Sorafenib Side Effects Report #5173185-X
Sorafenib side effect was reported by a Physician from GERMANY on June 16, 2006. Male patient, 65 years of age, weighting 99.21 lb, was diagnosed with insomnia, diabetes mellitus, pyrexia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEXOMIL, IMOVANE, ATHYMIL, GLUCOPHAGE, LANTUS, EFFERALGAN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5470960-9
Sorafenib side effect was reported by a Physician from GERMANY on Sept 26, 2007. Male patient, 65 years of age, weighting 99.21 lb, was diagnosed with insomnia, diabetes mellitus, pyrexia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEXOMIL, IMOVANE, ATHYMIL, GLUCOPHAGE, LANTUS, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5060063-X
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on July 12, 2006. Male patient, 64 years of age, weighting 99.21 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Sorafenib dosage: 400 MG, ORAL. During the same period patient was treated with LEXOMIL, IMOVANE, ATHYMIL, GLUCOPHAGE, LANTUS, ACETAMINOPHEN, FERROUS SULPHATE, DEXERYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5118376-9
Sorafenib side effect was reported by a Physician from FRANCE on June 26, 2006. Male patient, 60 years of age, was diagnosed with diabetes mellitus, hypertension, chest pain
, nausea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastatic renal cell carcinoma. Sorafenib dosage: UNIT DOSE: 200 MG. During the same period patient was treated with GLUCOPHAGE, BISOPROLOL FUMARATE, DIANTALVIC, DURAGESIC, PRIMPERAN, DIAMICRON, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 04/06/2006.Sorafenib Side Effects Report #5060368-2
Sorafenib side effect was reported by a Physician from FRANCE on July 12, 2006. Male patient, 59 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, malignant neoplasm progression. Sorafenib dosage: 400 MG, TOTAL DAILY, ORAL; 200 MG, TOTAL DAILY, ORAL. During the same period patient was treated with GLUCOPHAGE, BISOPROLOL FUMARATE, DIANTALVIC, DURAGESIC, PRIMPERAN, DIAMICRON, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 04/06/2006.
Sorafenib Side Effects Report #5070020-5
Sorafenib side effect was reported by a Physician from FRANCE on July 26, 2006. Male patient, 59 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastatic renal cell carcinoma. Sorafenib dosage: unknown. During the same period patient was treated with GLUCOPHAGE, BISOPROLOL FUMARATE, DIANTALVIC, DURAGESIC, PRIMPERAN, DIAMICRON, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 04/06/2006.
Sorafenib Side Effects Report #5190144-1
Sorafenib side effect was reported by a Physician from GERMANY on June 12, 2006. Female patient, 44 years of age, weighting 149.9 lb, was diagnosed with gastroenteritis
, hypertension, anaemia, pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: epilepsy , malignant neoplasm progression. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with CEFTRIAXON, METRONIDAZOLE, METOPROLOL SUCCINATE, FERRO SANOL, TILIDIN, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6107205-2
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2009. Male patient, weighting 211.2 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, malignant neoplasm progression. Sorafenib dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.